Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy for chronic hepatitis c infection

Combination therapy for chronic hepatitis c infection

US Patent 6299872 · Granted Oct 9, 2001

Estimated economic value: $130,348,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sulfonyl-substituted bicyclic compounds as PPAR modulators for the treatment of 2016
Ribavirin-pegylated interferon alfa induction HCV combination therapy2004
Treatment of hepatitis C virus infections with interleukin-102004
Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy2003
Combination therapy for eradicating detectable HCV-RNA in antiviral treatment na2002
Combination therapy for chronic hepatitis C infection2002
Combination therapy for chronic hepatitis C infection2002
Combination therapy for eradicating detectable HCV-RNA in patients having chroni2001